EVO
Price
$1.73
Change
-$0.04 (-2.26%)
Updated
Sep 11 closing price
Capitalization
627.96M
54 days until earnings call
Intraday BUY SELL Signals
EWD
Price
$51.90
Change
+$0.32 (+0.62%)
Updated
Sep 11 closing price
Net Assets
739.06M
Intraday BUY SELL Signals
Interact to see
Advertisement

EVO vs EWD

EVO vs EWD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
EVO vs. EWD commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVO is a Buy and EWD is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
EVO: Fundamental Ratings
EVO
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EVOEWD
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 17 days ago
67%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
77%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (EVO: $1.73)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVO’s FA Score shows that 1 FA rating(s) are green while .

  • EVO’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVO’s TA Score shows that 4 TA indicator(s) are bullish.

  • EVO’s TA Score: 4 bullish, 4 bearish.

Price Growth

EVO (@Pharmaceuticals: Generic) experienced а -6.99% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -5.31%. For the same industry, the average monthly price growth was -4.84%, and the average quarterly price growth was +30.17%.

Reported Earning Dates

EVO is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-5.31% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
EVO
Daily Signal:
Gain/Loss:
EWD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NCIGX38.56N/A
N/A
Nuveen International Value C
CHRSX22.81N/A
N/A
Invesco Charter S
TSLTX6.38N/A
N/A
Transamerica Small Cap Value I3
MIGOX33.78N/A
N/A
Marsico Global Institutional
FMAJX14.97N/A
N/A
Fidelity Advisor Magellan M

EWD and

Correlation & Price change

A.I.dvisor tells us that EWD and SPOT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EWD and SPOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EWD
1D Price
Change %
EWD100%
+0.62%
SPOT - EWD
29%
Poorly correlated
+0.77%
EVO - EWD
10%
Poorly correlated
-2.26%
EQT - EWD
-0%
Poorly correlated
-1.62%